End-to-End Drug Development Support from Concept to Commercialization

Taj Pharma offers a fully integrated pharmaceutical development ecosystem designed to accelerate the journey from molecule to market. Our vertically aligned capabilities cover early formulation conceptualization, regulatory strategy, pre-formulation, scale-up, BA/BE study management, manufacturing, and commercial launch. With a multidisciplinary team and cGMP-compliant infrastructure, Taj Pharma provides a seamless solution for pharmaceutical, nutraceutical, and specialty healthcare product development.

Our integrated approach ensures speed, efficiency, regulatory compliance, and technical excellence, enabling global partners to reduce development timelines while maintaining the highest quality standards.

1. Dosage Form Design & Patent Surveys

1.1 Advanced Dosage Form Design

Taj Pharma’s formulation scientists specialize in designing robust, patient-centric dosage forms optimized for stability, bioavailability, manufacturability, and regulatory acceptance.

We design:

  • Immediate-release (IR), extended-release (ER/MR), delayed-release (DR) formulations
  • Fixed-dose combinations (FDCs)
  • High-potency and low-dose formulations
  • Multiparticulate systems (pellets, granules, microcapsules)
  • Sterile injectables (liquid, lyophilized, PFS)
  • Ophthalmics, nasal sprays, suspensions, and emulsions
  • Pediatric-friendly dosage forms (ODTs, syrups, dispersible tablets)

Design factors considered include:

  • API solubility/permeability profile (BCS considerations)
  • Polymorphism and crystallinity
  • Target dissolution profile
  • Stability under ICH climatic zones
  • Patient compliance and dosing flexibility
  • Manufacturing scalability and commercial feasibility

1.2 Patent & IP Landscape Surveys

Before initiating development, Taj Pharma conducts a detailed patent landscape assessment to ensure regulatory and commercial freedom-to-operate (FTO).

This includes:

  • Evaluation of active substance patents
  • Formulation, excipient, polymorph, and process patents
  • Assessment of potential workarounds or non-infringing approaches
  • Para IV and FTF opportunity identification
  • Market exclusivity mapping
  • IP risk mitigation strategies for regulated markets

A thorough patent survey ensures the product is developed with maximum competitiveness and minimum infringement risk.

2. API & Excipient Sourcing

Taj Pharma maintains a strong global network of qualified API and excipient suppliers adhering to WHO-GMP, CEP, DMF, and global quality frameworks.

2.1 API Sourcing

We ensure:

  • Full DMF availability (USDMF/EDMF/ASMF/COS)
  • Impurity profile compatibility with formulation design
  • Particle-size distribution control
  • Polymorphic and crystalline structure consistency
  • Long-term supply assurance agreements
  • Comprehensive vendor audits and material risk assessments

2.2 Excipient Sourcing

Excipient selection is based on:

  • Regulatory acceptance across key markets
  • Functional performance in the final dosage form
  • Compatibility with API and packaging
  • Stability under ICH conditions
  • Quality grade (pharmaceutical, USP/NF/Ph. Eur.)

Taj Pharma’s procurement and QA teams work jointly to ensure high-quality, compliant, and reliable raw materials for development and scale-up.

3. Pre-Formulation, Bench-Scale & Lab-Scale Development

Our R&D laboratories are equipped to conduct comprehensive material characterization and small-scale formulation modeling.

3.1 Pre-Formulation Studies

We perform:

  • Physicochemical characterization (pKa, logP, solubility profile)
  • Polymorph screening & salt selection
  • Hygroscopicity and solid-state stability
  • Excipient compatibility studies
  • pH-solubility mapping
  • Particle-size engineering and micronization feasibility
  • Degradation pathway and risk mapping

These data points build a strong scientific foundation for formulation design and regulatory documentation.

3.2 Bench-Scale Formulation Development

At the bench-scale stage, Taj Pharma formulates prototypes under controlled conditions to evaluate:

  • Blend uniformity
  • Compressibility and granulation properties
  • Dissolution behavior
  • API-excipient interactions
  • Preliminary stability

Multiple prototype iterations are evaluated for:

  • Performance optimization
  • Manufacturability
  • Cost-effectiveness
  • Packaging compatibility

3.3 Lab-Scale Process Design & Optimization

Lab-scale batches are developed to:

  • Simulate commercial manufacturing parameters
  • Establish critical quality attributes (CQAs)
  • Identify critical process parameters (CPPs)
  • Prepare for process validation and scale-up

Using QbD tools (DOE, RPN scoring, risk assessment), Taj Pharma creates a robust and reproducible formulation process.

4. Scale-Up Processes & Regulatory Support

Taj Pharma provides smooth and risk-free scale-up for pilot and exhibit batches.

4.1 Pilot-Scale Manufacturing

Pilot batches are manufactured under cGMP to establish:

  • Equipment equivalence (lab → pilot → commercial)
  • Process robustness
  • Manufacturing feasibility
  • In-process controls (IPQC)
  • Scale-up-driven critical parameter adjustments

4.2 Process Validation & Commercial-Scale Optimization

Our process validation team executes:

  • Process Performance Qualification (PPQ)
  • Continued Process Verification (CPV)
  • Equipment qualification (IQ/OQ/PQ)
  • Cleaning validation
  • Hold time studies

This ensures regulatory readiness for WHO-GMP, PIC/S, USFDA, EMA, and other agencies.

4.3 Regulatory Documentation Support

Taj Pharma provides complete regulatory assistance, including:

  • CTD/eCTD preparation for Modules 1–5
  • Product dossiers for semi-regulated & regulated markets
  • Stability protocol designs
  • Risk assessment and justification documents
  • Complete CMC documentation
  • Query responses for regulatory authorities
  • Packaging & labelling compliance

Our Regulatory Affairs team ensures seamless product registration and global market entry.

5. Bioequivalence/Bioavailability (BA/BE) Studies

Taj Pharma supports BE/BA studies required for ANDA filings, generic approvals, and new formulation claims.

5.1 Clinical Study Management

Services include:

  • Protocol development
  • CRO selection and monitoring
  • Pharmacokinetic model design
  • Sample bioanalysis using LC-MS/MS
  • Data interpretation and statistics
  • Study report preparation for regulatory filing

5.2 In Vitro–In Vivo Correlation (IVIVC)

Where applicable, Taj Pharma establishes:

  • Level A, B, and C correlations
  • Dissolution method optimization
  • Predictive mathematical modeling
  • Bridging study recommendations

These studies ensure that the product meets the therapeutic performance standards required for market authorization.

6. Submission & Commercial Batches

Taj Pharma has full capability to manufacture submission-ready exhibit batches and commercial-ready production batches.

6.1 Exhibit/Submission Batches

Produced under cGMP using:

  • Scale-representative manufacturing conditions
  • Validated analytical methods
  • Robust stability programs
  • Accurate batch records for CTD regulatory submissions

Exhibit batches support:

  • ANDA/NDA/MAA filings
  • WHO prequalification
  • MOH submissions in global markets

6.2 Full-Scale Commercial Manufacturing

With advanced WHO-GMP & PIC/S-compliant manufacturing facilities, Taj Pharma ensures:

  • High-volume production of OSD, injectables, ophthalmics, and nutraceuticals
  • End-to-end quality assurance & batch certification
  • Extensive packaging options for regional market needs
  • Reliable supply chain management and distribution

Commercial batches follow:

  • Validated process parameters
  • Stringent QA oversight
  • Comprehensive release testing
  • Data integrity compliance

Taj Pharma’s Integrated Pharmaceutical Solutions provide a unified, end-to-end drug development framework designed to meet global quality, regulatory, and market expectations. From dosage form conceptualization and patent intelligence to pre-formulation, scale-up, BE studies, regulatory submissions, and commercial production, Taj Pharma delivers a complete and highly efficient development pathway.

Our seamless integration of scientific, technical, and regulatory expertise ensures faster time-to-market, reduced development risk, and consistent high-quality outcomes—making Taj Pharma a trusted partner for global pharmaceutical development and commercialization.